tiprankstipranks
Trending News
More News >
Adverum Biotechnologies (ADVM)
NASDAQ:ADVM
US Market

Adverum Biotechnologies (ADVM) Financial Statements

Compare
614 Followers

Adverum Biotechnologies Financial Overview

Adverum Biotechnologies's market cap is currently $46.59M. The company's EPS TTM is $-2.25; its P/E ratio is ―; Adverum Biotechnologies is scheduled to report earnings on May 14, 2025, and the estimated EPS forecast is $-2.08. See an overview of income statement, balance sheet, and cash flow financials.
Dec 24Dec 23Dec 22Dec 21Dec 20
Income Statement
Total Revenue$ 1.00M$ 3.60M$ 0.00$ 7.50M$ 0.00
Gross Profit$ -2.65M$ -2.04M$ -6.53M$ 2.85M$ -4.16M
Operating Income$ -139.16M$ -123.99M$ -157.13M$ -146.12M$ -117.95M
EBITDA$ -127.27M$ -118.35M$ -147.93M$ -140.90M$ -112.23M
Net Income$ -130.93M$ -117.17M$ -154.54M$ -145.54M$ -117.51M
Balance Sheet
Cash & Short-Term Investments$ 125.69M$ 96.53M$ 185.59M$ 305.19M$ 429.73M
Total Assets$ 179.84M$ 173.01M$ 308.37M$ 439.73M$ 482.57M
Total Debt$ 91.70M$ 75.04M$ 106.80M$ 102.99M$ 30.71M
Net Debt$ 31.05M$ 36.00K$ 38.37M$ 68.80M$ -31.72M
Total Liabilities$ 109.13M$ 89.54M$ 126.85M$ 123.54M$ 48.22M
Stockholders' Equity$ 70.71M$ 83.47M$ 181.52M$ 316.19M$ 434.35M
Cash Flow
Free Cash Flow$ -92.85M$ -91.71M$ -119.91M$ -122.95M$ -91.14M
Operating Cash Flow$ -92.46M$ -90.90M$ -108.09M$ -107.83M$ -79.29M
Investing Cash Flow$ -41.89M$ 96.88M$ 141.72M$ 78.71M$ -280.17M
Financing Cash Flow$ 120.00M$ 69.00K$ 607.00K$ 2.40M$ 355.99M
Currency in USD

Adverum Biotechnologies Earnings and Revenue History

Adverum Biotechnologies Debt to Assets

Adverum Biotechnologies Cash Flow

Adverum Biotechnologies Forecast EPS vs Actual EPS

What am I Missing?
Make informed decisions based on Top Analysts' activity
Know what industry insiders are buying
Get actionable alerts from top Wall Street Analysts
Find out before anyone else which stock is going to shoot up
Get powerful stock screeners & detailed portfolio analysis